Table 2 Public health and economic impact of a universal vaccination program vs. no vaccination program for base case scenario
From: Cost effectiveness of a pentavalent rotavirus vaccine in Oman
No vaccination program | Universal vaccination program | Net difference | Percent reduction | |
|---|---|---|---|---|
Events | ||||
Deaths | 6 | 0.65 | -5 | -89.1% |
Hospitalizations | 4,279 | 466.06 | -3,813 | -89.1% |
ED visits | 3,294 | 650.01 | -2,644 | -80.3% |
Outpatient visits | 14,838 | 4,951.67 | -9,886 | -66.6% |
Work loss days | 30,068 | 7,867.45 | -22,200 | -73.8% |
Costs, OMR (USD) | ||||
Medical care costs | 1,338,977 (3,481,340) | 216,646 (563,279.6) | -1,122,331 (-2,918,061) | -83.8% |
Hospitalization costs | 871,083 (2,264,816) | 73,043 (189,911.8) | -798,041 (-2,074,907) | -91.6% |
ED visit costs | 85,001 (221,002.6) | 16,659 (43,313.4) | -68,342 (-177,689) | -80.4% |
Outpatient visit costs | 382,893 (995,521.8) | 126,944 (330,054.4) | -255,949 (-665,467) | -66.8% |
Direct non-medical costs | 347,527 (903,570.2) | 137,216 (356,761.6) | -210,311 (-546,809) | -60.5% |
Indirect (work days lost) costs | 336,533 (874985.8) | 89,758 (233,370.8) | -246,776 (-641,618) | -73.3% |
Societal costs | 2,023,038 (5259,899) | 443,619 (1,153,409) | -1,579,419 (-4,106,489) | -78.1% |
Vaccination costs | 0 | 1,465,752 (3,810,955) | ||
Net direct medical care costs | 1,338,977 (3,481,340) | 1,682,398 (4,374,235) | 343,421 (892,894.6) | 25.7% |
Net societal costs | 2,023,038 (5,259,899) | 1,909,371 (4,964,365) | -113,667 (-295,534) | -5.6% |